Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model

Epigallocatechin-3-gallate (EGCG) is a candidate for treatment of Alzheimer's disease (AD) but its inherent instability limits bioavailability and effectiveness. We found that EGCG displayed increased stability when formulated as dual-drug loaded PEGylated PLGA nanoparticles (EGCG/AA NPs). Oral...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Control Release
Главные авторы: Cano, Amanda, Ettcheto, Miren, Chang, Jui-Hsien, Barroso, Emma, Espina, Marta, Kühne, Britta A., Barenys, Marta, Auladell, Carmen, Folch, Jaume, Souto, Eliana B., Camins, Antoni, Turowski, Patric, García, Maria Luisa
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier Science Publishers 2019
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6510952/
https://ncbi.nlm.nih.gov/pubmed/30876953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2019.03.010
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы